Gems, D. et al. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150, 129–155 (1998).
Murphy, C. T. et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277–283 (2003).
Lee, S. S., Kennedy, S., Tolonen, A. C. & Ruvkun, G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 300, 644–647 (2003).
Jenkins, N. L., McColl, G. & Lithgow, G. J. Fitness cost of extended lifespan in Caenorhabditis elegans. Proc. Biol. Sci. 271, 2523–2526 (2004).
Kenyon, C. The plasticity of aging: insights from long-lived mutants. Cell 120, 449–460 (2005). This is one of the first papers to show that a single specific genetic mutation (daf-2) can increase lifespan and can be reverted by a second mutation (daf-16), revealing a connection between insulin signalling and lifespan.
Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A. C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993).
Willcox, B. J. et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl Acad. Sci. USA 105, 13987–13992 (2008).
Santo, E. E. et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell 22, e13763 (2023).
Eijkelenboom, A. & Burgering, B. M. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83–97 (2013).
Liang, R. & Ghaffari, S. Stem cells seen through the FOXO lens: an evolving paradigm. Curr. Top. Dev. Biol. 127, 23–47 (2018).
Tothova, Z. et al. FoxOs are critical mediators of hematopoietic stem cell resistance physiologic oxid. stress. Cell 128, 325–339 (2007). This study shows the redundancy of FOXO1, FOXO3 and FOXO4 in HSC maintenance and that antioxidant defence downstream of FOXO is a key driver of stem cell maintenance.
Shimokawa, I. et al. The life-extending effect of dietary restriction requires Foxo3 in mice. Aging Cell 14, 707–709 (2015).
Hwang, I. et al. FOXO protects against age-progressive axonal degeneration. Aging Cell 17, e12701 (2018).
Du, S. et al. FoxO3 deficiency in cortical astrocytes leads to impaired lipid metabolism and aggravated amyloid pathology. Aging Cell 20, e13432 (2021).
Hedrick, S. M., Hess Michelini, R., Doedens, A. L., Goldrath, A. W. & Stone, E. L. FOXO transcription factors throughout T cell biology. Nat. Rev. Immunol. 12, 649–661 (2012).
Calissi, G., Lam, E. W. & Link, W. Therapeutic strategies targeting FOXO transcription factors. Nat. Rev. Drug Discov. 20, 21–38 (2021).
Brown, A. K. & Webb, A. E. Regulation of FOXO factors in mammalian cells. Curr. Top. Dev. Biol. 127, 165–192 (2018).
Calnan, D. R. & Brunet, A. The FoxO code. Oncogene 27, 2276–2288 (2008).
Franz, F. et al. The transcriptional regulation of FOXO genes in thyrocytes. Horm. Metab. Res. 48, 601–606 (2016).
Urbanek, P. & Klotz, L. O. Posttranscriptional regulation of FOXO expression: microRNAs and beyond. Br. J. Pharmacol. 174, 1514–1532 (2017).
Asmamaw, M. D., Liu, Y., Zheng, Y. C., Shi, X. J. & Liu, H. M. Skp2 in the ubiquitin–proteasome system: a comprehensive review. Med. Res. Rev. 40, 1920–1949 (2020).
Brenkman, A. B., de Keizer, P. L., van den Broek, N. J., Jochemsen, A. G. & Burgering, B. M. Mdm2 induces mono-ubiquitination of FOXO4. PLoS ONE 3, e2819 (2008).
Huang, H. & Tindall, D. J. Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim. Biophys. Acta 1813, 1961–1964 (2011).
Wang, X., Wang, J. & Jiang, X. MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J. Biol. Chem. 286, 23725–23734 (2011).
Grossman, S. R. et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342–344 (2003).
Zhou, B. P. et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3, 973–982 (2001).
Mayo, L. D. & Donner, D. B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl Acad. Sci. USA 98, 11598–11603 (2001).
van der Horst, A. et al. FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat. Cell Biol. 8, 1064–1073 (2006).
Heimbucher, T. & Hunter, T. The C. elegans ortholog of USP7 controls DAF-16 stability in insulin/IGF-1-like signaling. Worm 4, e1103429 (2015).
Kops, G. J. et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634 (1999).
Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96, 857–868 (1999). This study and the study by Kops et al. (1999) are the first to show that the regulation of FOXOs, the orthologues of DAF-16 in mammalians, are directly controlled by AKT and PI3K signalling, thereby showing evolutionary conservation.
Brownawell, A. M., Kops, G. J., Macara, I. G. & Burgering, B. M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell Biol. 21, 3534–3546 (2001).
Essers, M. A. et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23, 4802–4812 (2004).
Putker, M. et al. Redox-dependent control of FOXO/DAF-16 by transportin-1. Mol. Cell 49, 730–742 (2013).
Putker, M. et al. Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling. Antioxid. Redox Signal. 22, 15–28 (2015).
Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227–2241 (2011).
Clark, K. L., Halay, E. D., Lai, E. & Burley, S. K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364, 412–420 (1993).
Wang, F. et al. Biochemical and structural characterization of an intramolecular interaction in FOXO3a and its binding with p53. J. Mol. Biol. 384, 590–603 (2008).
Bourgeois, B. et al. Multiple regulatory intrinsically disordered motifs control FOXO4 transcription factor binding and function. Cell Rep. 36, 109446 (2021).
Obsil, T. & Obsilova, V. Structural basis for DNA recognition by FOXO proteins. Biochim. Biophys. Acta 1813, 1946–1953 (2011).
Li, J. et al. Mechanism of forkhead transcription factors binding to a novel palindromic DNA site. Nucleic Acids Res. 49, 3573–3583 (2021).
Psenakova, K. et al. Forkhead domains of FOXO transcription factors differ in both overall conformation and dynamics. Cells 8, 966 (2019).
Sugase, K., Dyson, H. J. & Wright, P. E. Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447, 1021–1025 (2007).
Shoemaker, B. A., Portman, J. J. & Wolynes, P. G. Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl Acad. Sci. USA 97, 8868–8873 (2000).
Dansen, T. B. et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 5, 664–672 (2009). This study is among the first to show that redox signalling, similar to growth factor signalling, proceeds through protein–protein interactions that are enforced by redox-sensitive cysteine disulfide bridges.
Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 21, 363–383 (2020).
van der Horst, A. et al. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2. J. Biol. Chem. 279, 28873–28879 (2004).
Yoshimochi, K., Daitoku, H. & Fukamizu, A. PCAF represses transactivation function of FOXO1 in an acetyltransferase-independent manner. J. Recept. Signal Transduct. Res. 30, 43–49 (2010).
Adamowicz, M., Vermezovic, J. & d’Adda di Fagagna, F. NOTCH1 inhibits activation of ATM by impairing the formation of an ATM-FOXO3a-KAT5/Tip60 complex. Cell Rep. 16, 2068–2076 (2016).
Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004). This study, together with van der Horst et al. (2004) provides a mechanistic link between FOXO and SIRT, which were independently shown to affect lifespan.
Daitoku, H. et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl Acad. Sci. USA 101, 10042–10047 (2004).
Tseng, A. H., Wu, L. H., Shieh, S. S. & Wang, D. L. SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. Biochem. J. 464, 157–168 (2014).
Mihaylova, M. M. et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607–621 (2011).
Daitoku, H., Sakamaki, J. & Fukamizu, A. Regulation of FoxO transcription factors by acetylation and protein–protein interactions. Biochim. Biophys. Acta 1813, 1954–1960 (2011).
Riedel, C. G. et al. DAF-16 employs the chromatin remodeller SWI/SNF to promote stress resistance and longevity. Nat. Cell Biol. 15, 491–501 (2013).
Webb, A. E. & Brunet, A. FOXO flips the longevity SWItch. Nat. Cell Biol. 15, 444–446 (2013).
Mattila, J., Kallijarvi, J. & Puig, O. RNAi screening for kinases and phosphatases identifies FoxO regulators. Proc. Natl Acad. Sci. USA 105, 14873–14878 (2008).
Liu, J. et al. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. Nat. Commun. 9, 5200 (2018).
Webb, A. E., Kundaje, A. & Brunet, A. Characterization of the direct targets of FOXO transcription factors throughout evolution. Aging Cell 15, 673–685 (2016).
Hao, N. & O’Shea, E. K. Signal-dependent dynamics of transcription factor translocation controls gene expression. Nat. Struct. Mol. Biol. 19, 31–39 (2011).
Demirbas, B. et al. Control of C. elegans growth arrest by stochastic, yet synchronized DAF-16/FOXO nuclear translocation pulses. Preprint at bioRxiv https://doi.org/10.1101/2023.07.05.547674 (2023).
Lasick, K. A. et al. FOXO nuclear shuttling dynamics are stimulus-dependent and correspond with cell fate. Mol. Biol. Cell 34, ar21 (2023).
Hatta, M. & Cirillo, L. A. Chromatin opening and stable perturbation of core histone: DNA contacts by FoxO1. J. Biol. Chem. 282, 35583–35593 (2007).
Hatta, M., Liu, F. & Cirillo, L. A. Acetylation curtails nucleosome binding, not stable nucleosome remodeling, by FoxO1. Biochem. Biophys. Res. Commun. 379, 1005–1008 (2009).
Eijkelenboom, A., Mokry, M., Smits, L. M., Nieuwenhuis, E. E. & Burgering, B. M. FOXO3 selectively amplifies enhancer activity to establish target gene regulation. Cell Rep. 5, 1664–1678 (2013).
Newman, J. R. et al. Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature 441, 840–846 (2006).
Allgayer, J., Kitsera, N., Bartelt, S., Epe, B. & Khobta, A. Widespread transcriptional gene inactivation initiated by a repair intermediate of 8-oxoguanine. Nucleic Acids Res. 44, 7267–7280 (2016).
Desai, R. V. et al. A DNA repair pathway can regulate transcriptional noise to promote cell fate transitions. Science 373, eabc6506 (2021).
Raser, J. M. & O’Shea, E. K. Noise in gene expression: origins, consequences, and control. Science 309, 2010–2013 (2005).
Munsky, B., Neuert, G. & van Oudenaarden, A. Using gene expression noise to understand gene regulation. Science 336, 183–187 (2012).
Wong, V. C. et al. NF-kappaB-chromatin interactions drive diverse phenotypes by modulating transcriptional noise. Cell Rep. 22, 585–599 (2018).
Comandante-Lou, N., Baumann, D. G. & Fallahi-Sichani, M. AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells. Cell Rep. 40, 111147 (2022).
Bahar, R. et al. Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature 441, 1011–1014 (2006).
Somel, M., Khaitovich, P., Bahn, S., Paabo, S. & Lachmann, M. Gene expression becomes heterogeneous with age. Curr. Biol. 16, R359–R360 (2006).
Rangaraju, S. et al. Suppression of transcriptional drift extends C. elegans lifespan by postponing the onset of mortality. eLife 4, e08833 (2015).
Cheung, P. et al. Single-cell chromatin modification profiling reveals increased epigenetic variations with aging. Cell 173, 1385–1397.e14 (2018).
Burgess, D. J. Human epigenetics: showing your age. Nat. Rev. Genet. 14, 6 (2013).
Booth, L. N. & Brunet, A. The aging epigenome. Mol. Cell 62, 728–744 (2016).
Fielenbach, N. & Antebi, A. C. elegans Dauer formation and the molecular basis of plasticity. Genes Dev. 22, 2149–2165 (2008).
Medema, R. H., Kops, G. J., Bos, J. L. & Burgering, B. M. AFX-like forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782–787 (2000). This study links FOXO function to inhibition of the cell cycle, thereby suggesting a role for FOXOs in tissue homeostasis and cancer.
Furukawa-Hibi, Y., Yoshida-Araki, K., Ohta, T., Ikeda, K. & Motoyama, N. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J. Biol. Chem. 277, 26729–26732 (2002).
Hornsveld, M. et al. A FOXO-dependent replication checkpoint restricts proliferation of damaged cells. Cell Rep. 34, 108675 (2021).
Sekimoto, T., Fukumoto, M. & Yoneda, Y. 14-3-3 Suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). EMBO J. 23, 1934–1942 (2004).
Blain, S. W. & Massague, J. Breast cancer banishes p27 from nucleus. Nat. Med. 8, 1076–1078 (2002).
Gao, D. et al. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat. Cell Biol. 11, 397–408 (2009).
Huang, H. et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl Acad. Sci. USA 102, 1649–1654 (2005).
Shtivelman, E., Sussman, J. & Stokoe, D. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr. Biol. 12, 919–924 (2002).
Kamura, T. et al. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat. Cell Biol. 6, 1229–1235 (2004).
Ou, L. et al. Incomplete folding upon binding mediates Cdk4/cyclin D complex activation by tyrosine phosphorylation of inhibitor p27 protein. J. Biol. Chem. 286, 30142–30151 (2011).
Coller, H. A., Sang, L. & Roberts, J. M. A new description of cellular quiescence. PLoS Biol. 4, e83 (2006).
Grana, X., Garriga, J. & Mayol, X. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17, 3365–3383 (1998).
Smith, E. J., Leone, G., DeGregori, J., Jakoi, L. & Nevins, J. R. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol. Cell Biol. 16, 6965–6976 (1996).
Kops, G. J. et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol. Cell Biol. 22, 2025–2036 (2002).
Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513–522 (2005).
Nogueira, V. et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458–470 (2008).
de Keizer, P. L. et al. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence. Cancer Res. 70, 8526–8536 (2010).
Baar, M. P. et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169, 132–147.e16 (2017). This paper shows that FOXOs can be a target for the specific elimination of senescent cells in order to mitigate age-related decline.
Munoz-Espin, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104–1118 (2013).
Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119–1130 (2013).
Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298–300 (1956).
Honda, Y. & Honda, S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 13, 1385–1393 (1999). This is the first study to show that DAF-16 regulates the expression of antioxidant enzymes, providing a link between the free radical theory of ageing and DAF-16-dependent lifespan extension.
Honda, Y. & Honda, S. Life span extensions associated with upregulation of gene expression of antioxidant enzymes in Caenorhabdms elegans; studies of mutation in the AGE-1, PI3 kinase homologue and short-term exposure to hyperoxia. J. Am. Aging Assoc. 24, 179–186 (2001).
Paik, J. H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309–323 (2007).
Klotz, L. O. et al. Redox regulation of FoxO transcription factors. Redox Biol. 6, 51–72 (2015).
Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Biol. 23, 499–515 (2022).
Netto, L. E. S. & Machado, L. Preferential redox regulation of cysteine-based protein tyrosine phosphatases: structural and biochemical diversity. FEBS J. 289, 5480–5504 (2022).
Snyder, N. A. & Silva, G. M. Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response. J. Biol. Chem. 297, 101077 (2021).
Wang, Y. & Hekimi, S. Mitochondrial dysfunction and longevity in animals: untangling the knot. Science 350, 1204–1207 (2015).
Van Raamsdonk, J. M. & Hekimi, S. Superoxide dismutase is dispensable for normal animal lifespan. Proc. Natl Acad. Sci. USA 109, 5785–5790 (2012).
Hoehne, M. N. et al. Spatial and temporal control of mitochondrial H(2) O(2) release in intact human cells. EMBO J. 41, e109169 (2022).
Saeedi Saravi, S. S. et al. Differential endothelial signaling responses elicited by chemogenetic H(2)O(2) synthesis. Redox Biol. 36, 101605 (2020).
Gross, D. N., van den Heuvel, A. P. & Birnbaum, M. J. The role of FoxO in the regulation of metabolism. Oncogene 27, 2320–2336 (2008).
Postic, C., Dentin, R. & Girard, J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 30, 398–408 (2004).
Altomonte, J. et al. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J. Clin. Invest. 114, 1493–1503 (2004).
Bastie, C. C. et al. FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J. Biol. Chem. 280, 14222–14229 (2005).
Kamei, Y. et al. A forkhead transcription factor FKHR up-regulates lipoprotein lipase expression in skeletal muscle. FEBS Lett. 536, 232–236 (2003).
Belgardt, B. F. et al. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab. 7, 291–301 (2008).
Kim, M. S. et al. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 9, 901–906 (2006).
Kitamura, T. et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12, 534–540 (2006).
Ren, H. et al. FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 149, 1314–1326 (2012).
Peck, B., Ferber, E. C. & Schulze, A. Antagonism between FOXO and MYC regulates cellular powerhouse. Front. Oncol. 3, 96 (2013).
Li, F. et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell Biol. 25, 6225–6234 (2005).
Ferber, E. C. et al. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 19, 968–979 (2012).
Cheng, Z. et al. Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat. Med. 15, 1307–1311 (2009).
Chan, D. C. Mitochondrial dynamics and its involvement in disease. Annu. Rev. Pathol. 15, 235–259 (2020).
Wang, K. et al. miR-484 regulates mitochondrial network through targeting Fis1. Nat. Commun. 3, 781 (2012).
Mei, Y. et al. FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation. Proc. Natl Acad. Sci. USA 106, 5153–5158 (2009).
Cheng, Z. FoxO transcription factors in mitochondrial homeostasis. Biochem. J. 479, 525–536 (2022).
Munoz-Martin, N., Sierra, R., Schimmang, T., Villa Del Campo, C. & Torres, M. Myc is dispensable for cardiomyocyte development but rescues Mycn-deficient hearts through functional replacement and cell competition. Development 146, dev170753 (2019).
Muncan, V. et al. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol. Cell Biol. 26, 8418–8426 (2006).
Sansom, O. J. et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676–679 (2007).
Lettieri-Barbato, D. et al. FoxO1 localizes to mitochondria of adipose tissue and is affected by nutrient stress. Metabolism 95, 84–92 (2019).
Caballero-Caballero, A. et al. Mitochondrial localization of the forkhead box class O transcription factor FOXO3a in brain. J. Neurochem. 124, 749–756 (2013).
Spinelli, J. B. & Haigis, M. C. The multifaceted contributions of mitochondria to cellular metabolism. Nat. Cell Biol. 20, 745–754 (2018).
Chakrabarty, R. P. & Chandel, N. S. Mitochondria as signaling organelles control mammalian stem cell fate. Cell Stem Cell 28, 394–408 (2021).
Klimovich, A. et al. Non-senescent hydra tolerates severe disturbances in the nuclear lamina. Aging 10, 951–972 (2018).
Martinez, D. E. Mortality patterns suggest lack of senescence in hydra. Exp. Gerontol. 33, 217–225 (1998).
Boehm, A. M. et al. FoxO is a critical regulator of stem cell maintenance in immortal Hydra. Proc. Natl Acad. Sci. USA 109, 19697–19702 (2012).
Bridge, D. et al. FoxO and stress responses in the cnidarian Hydra vulgaris. PLoS ONE 5, e11686 (2010). This is the first paper to show that FOXO is expressed in the cnidarian H. vulgaris, and that FOXO-dependent adaptation to stress was introduced early in animal evolution.
Schultz, M. B. & Sinclair, D. A. When stem cells grow old: phenotypes and mechanisms of stem cell aging. Development 143, 3–14 (2016).
Li, L. & Clevers, H. Coexistence of quiescent and active adult stem cells in mammals. Science 327, 542–545 (2010).
Paik, J. H. et al. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 5, 540–553 (2009).
Renault, V. M. et al. FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5, 527–539 (2009).
Garcia-Prat, L. et al. FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age. Nat. Cell Biol. 22, 1307–1318 (2020).
Wang, G. et al. p110alpha of PI3K is necessary and sufficient for quiescence exit in adult muscle satellite cells. EMBO J. 37, e98239 (2018).
Yue, F. et al. Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nat. Commun. 8, 14328 (2017).
Miyamoto, K. et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1, 101–112 (2007).
Tothova, Z. & Gilliland, D. G. FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system. Cell Stem Cell 1, 140–152 (2007).
Castrillon, D. H., Miao, L., Kollipara, R., Horner, J. W. & DePinho, R. A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301, 215–218 (2003). This study establishes a link between FOXO function and fecundity in mice, thereby establishing a FOXO-dependent evolutionary conserved trade-off between fecundity and lifespan.
Tissenbaum, H. A. & Ruvkun, G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148, 703–717 (1998).
Giannakou, M. E. et al. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305, 361 (2004).
Schaffner, I. et al. FoxO function is essential for maintenance of autophagic flux and neuronal morphogenesis in adult neurogenesis. Neuron 99, 1188–1203.e6 (2018).
Yeo, H. et al. FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells. EMBO J. 32, 2589–2602 (2013).
Gopinath, S. D., Webb, A. E., Brunet, A. & Rando, T. A. FOXO3 promotes quiescence in adult muscle stem cells during the process of self-renewal. Stem Cell Rep. 2, 414–426 (2014). This paper, together with Garcia-Prat et al. (2020), shows the role of FOXOs and redox regulation in quiescent adult (muscle) stem cells.
Zhang, L., Issa Bhaloo, S., Chen, T., Zhou, B. & Xu, Q. Role of resident stem cells in vessel formation and arteriosclerosis. Circ. Res. 122, 1608–1624 (2018).
Andrade, J. et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat. Cell Biol. 23, 413–423 (2021).
Wilhelm, K. et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium. Nature 529, 216–220 (2016).
Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J. & Schofield, C. J. 2-Oxoglutarate-dependent oxygenases. Annu. Rev. Biochem. 87, 585–620 (2018).
Charitou, P. et al. FOXOs support the metabolic requirements of normal and tumor cells by promoting IDH1 expression. EMBO Rep. 16, 456–466 (2015).
Ito, K. et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 997–1002 (2004).
Kim, J. & Wong, P. K. Loss of ATM impairs proliferation of neural stem cells through oxidative stress-mediated p38 MAPK signaling. Stem Cell 27, 1987–1998 (2009).
Jones, R. M. et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 32, 3017–3028 (2013).
Rodriguez-Colman, M. J. et al. Interplay between metabolic identities in the intestinal crypt supports stem cell function. Nature 543, 424–427 (2017). One of the first studies that shows metabolic crosstalk between niche and stem cells, thereby showing that next to growth factors, metabolites also act as crucial signalling molecules in stem cell maintenance.
Le Belle, J. E. et al. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 8, 59–71 (2011).
Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412 (2004).
Cerletti, M., Jang, Y. C., Finley, L. W., Haigis, M. C. & Wagers, A. J. Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 10, 515–519 (2012).
Benjamin, D. I. et al. Fasting induces a highly resilient deep quiescent state in muscle stem cells via ketone body signaling. Cell Metab. 34, 902–918.e6 (2022).
van Gastel, N. et al. Lipid availability determines fate of skeletal progenitor cells via SOX9. Nature 579, 111–117 (2020). This study shows how FOXO can sense the metabolic environment and, in response, specify cell differentiation.
Matsuzaki, T. et al. FoxO transcription factors modulate autophagy and proteoglycan 4 in cartilage homeostasis and osteoarthritis. Sci. Transl Med 10, eaan0746 (2018).
Beumer, J. & Clevers, H. Cell fate specification and differentiation in the adult mammalian intestine. Nat. Rev. Mol. Cell Biol. 22, 39–53 (2021).
Schell, J. C. et al. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat. Cell Biol. 19, 1027–1036 (2017).
Ludikhuize, M. C. et al. Mitochondria define intestinal stem cell differentiation downstream of a FOXO/Notch axis. Cell Metab. 32, 889–900.e7 (2020).
Kaiko, G. E. et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 165, 1708–1720 (2016).
Chen, Z. et al. Foxo1 controls gut homeostasis and commensalism by regulating mucus secretion. J. Exp. Med. 218, e20210324 (2021).
Zhao, Y. et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12, 665–675 (2010).
Hornsveld, M. et al. FOXO transcription factors both suppress and support breast cancer progression. Cancer Res. 78, 2356–2369 (2018).
Sykes, S. M. et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 146, 697–708 (2011). This is the first study to show that FOXOs not only act as tumour suppressor but also promote tumorigenesis.
Ng, S. W. K. et al. Convergent somatic mutations in metabolism genes in chronic liver disease. Nature 598, 473–478 (2021).
Sullivan, L. B. & Chandel, N. S. Mitochondrial reactive oxygen species and cancer. Cancer Metab. 2, 17 (2014).
Kensler, T. W. & Wakabayashi, N. Nrf2: friend or foe for chemoprevention. Carcinogenesis 31, 90–99 (2010).
Sporn, M. B. & Liby, K. T. NRF2 and cancer: the good, the bad and the importance of context. Nat. Rev. Cancer 12, 564–571 (2012).
O’Reilly, D. R. p53 and transformation by SV40. Biol. Cell 57, 187–196 (1986).
Levine, A. J. p53: 800 million years of evolution and 40 years of discovery. Nat. Rev. Cancer 20, 471–480 (2020).
Furuyama, T., Nakazawa, T., Nakano, I. & Mori, N. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem. J. 349, 629–634 (2000).
Brunet, A. et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156, 817–828 (2002).
Wang, F. et al. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment. Proc. Natl Acad. Sci. USA 109, 6078–6083 (2012).
Wang, F. et al. Synergistic interplay between promoter recognition and CBP/p300 coactivator recruitment by FOXO3a. ACS Chem. Biol. 4, 1017–1027 (2009).
Feringa, F. M. et al. Hypersensitivity to DNA damage in antephase as a safeguard for genome stability. Nat. Commun. 7, 12618 (2016).
Chin, C. F. & Yeong, F. M. Safeguarding entry into mitosis: the antephase checkpoint. Mol. Cell Biol. 30, 22–32 (2010).
Shats, I. et al. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. Cancer Res. 73, 6056–6067 (2013).
Krenning, L., Feringa, F. M., Shaltiel, I. A., van den Berg, J. & Medema, R. H. Transient activation of p53 in G2 phase is sufficient to induce senescence. Mol. Cell 55, 59–72 (2014).
Krenning, L., van den Berg, J. & Medema, R. H. Life or death after a break: what determines the choice. Mol. Cell 76, 346–358 (2019).
Hoxhaj, G. & Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74–88 (2020).
Rim, E. Y., Clevers, H. & Nusse, R. The wnt pathway: from signaling mechanisms to synthetic modulators. Annu. Rev. Biochem. 91, 571–598 (2022).
Daniels, D. L. & Weis, W. I. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12, 364–371 (2005).
Hoogeboom, D. et al. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. J. Biol. Chem. 283, 9224–9230 (2008).
Almeida, M., Han, L., Martin-Millan, M., O’Brien, C. A. & Manolagas, S. C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J. Biol. Chem. 282, 27298–27305 (2007).
Liu, H. et al. Wnt signaling regulates hepatic metabolism. Sci. Signal. 4, ra6 (2011).
Shi, T., van Soest, D. M. K., Polderman, P. E., Burgering, B. M. T. & Dansen, T. B. DNA damage and oxidant stress activate p53 through differential upstream signaling pathways. Free Radic. Biol. Med. 172, 298–311 (2021).
Fuentes-Lemus, E. & Davies, M. J. Effect of crowding, compartmentalization and nanodomains on protein modification and redox signaling — current state and future challenges. Free Radic. Biol. Med. 196, 81–92 (2023).
Sies, H., Berndt, C. & Jones, D. P. Oxidative stress. Annu. Rev. Biochem. 86, 715–748 (2017).
Marabelli, C., Marrocco, B. & Mattevi, A. The growing structural and functional complexity of the LSD1/KDM1A histone demethylase. Curr. Opin. Struct. Biol. 41, 135–144 (2016).
Bai, J. et al. Actin reduction by MsrB2 is a key component of the cytokinetic abscission checkpoint and prevents tetraploidy. Proc. Natl Acad. Sci. USA 117, 4169–4179 (2020).
Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D. & Miki, Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat. Cell Biol. 7, 278–285 (2005).
Hopkins, B. L. et al. A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7. Antioxid. Redox Signal. 28, 62–77 (2018).
Kong, H. & Chandel, N. S. Regulation of redox balance in cancer and T cells. J. Biol. Chem. 293, 7499–7507 (2018).
Bansal, A. et al. Transcriptional regulation of Caenorhabditis elegans FOXO/DAF-16 modulates lifespan. Longev. Healthspan 3, 5 (2014).
Guertin, D. A. et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859–871 (2006).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Automotive / EVs, Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- ChartPrime. Elevate your Trading Game with ChartPrime. Access Here.
- BlockOffsets. Modernizing Environmental Offset Ownership. Access Here.
- Source: https://www.nature.com/articles/s41580-023-00649-0